v3 Template
S

Sirius Therapeutics

Biotechnology ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$50.0M
Funding Rounds
1
Last Funding
2025-05-09

About Sirius Therapeutics

Sirius Therapeutics, Inc. is an innovative biotech company focused on developing novel RNAi therapies for global markets, with a mission to advance transformative siRNA therapeutics for patients with chronic diseases, particularly addressing significant cardiovascular risks.

Products & Services

RNAi Therapies:Novel siRNA therapeutics leveraging RNAi technology to offer innovative medical solutions for patients, especially targeting cardiovascular diseases.

Specialties

RNAi Technology siRNA Therapeutics Cardiovascular Disease Solutions

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B2
T: -
FT: Series B2 		A: 50000000
MR: -
FA: nearly $50 million
FAN: 50000000 		D: 2025-05-09
FD: 2025-05-09 		5 investors
Series B2 Latest
2025-05-09
$50.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Q

Qunsheng Ji

Chief Executive Officer

C

Curt Bradshaw

Chief Scientific Officer

P

Patrick Yue

Chief Medical Officer

D

David Li

SVP, Non-clinical Development

D

David Wang

Chairman

W

Wei Li

Board Director

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Sirius Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~135 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro